A carregar...
Benefit‐Risk Assessment of Current Antiarrhythmic Drug Therapy of Atrial Fibrillation
Over the last decade, several rhythm‐versus rate‐control trails in patients with atrial fibrillation (AF) have failed to demonstrate benefit of the rhythm control strategy with respect to mortality and morbidity. This had let to the guideline recommendation that antiarrhythmic drug therapy should be...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6652313/ https://ncbi.nlm.nih.gov/pubmed/22246949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20959 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...